Big Week Ahead: Autos, Pharma and a Russell Shakeup

European carmakers dominate Wednesday and Thursday. Mercedes-Benz Group reports today. Dutch car registration data tracked by ORTEX Alt Data is running 6% below the same quarter last year. That is a cautious backdrop for the print.

Volkswagen and Renault both report Thursday. Austrian car registrations, a leading indicator for VW revenue, are also down 6% year-on-year. For Renault, the same Austrian dataset points to a 6% rise but Dutch registrations are running 19% lower. The two signals pull in opposite directions.

Ferrari rounds out the auto season on Monday. Austrian registrations tied to its revenue are running 75% below last year's quarter, though ORTEX flags this as a weak statistical fit.

In the US, Murphy USA posts today. AvalonBay Communities also reports Wednesday. No significant IPOs are scheduled this week.

The Russell rebalance looms large. Twist Bioscience jumped overnight to a 55% probability of leaving the Russell 2000 and joining the Russell 1000. The ranking cut-off falls Thursday. A Russell 1000 inclusion would trigger an estimated $529 million of forced buying.

Eurofins Scientific and Swatch Group also release results today on the European side, adding to a packed start to the week.